HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

indirubin-3'-monoxime

has antiangiogenic activity
Also Known As:
indirubin 3'-oxime
Networked: 34 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Ichimaru, Yoshimi: 4 articles (12/2019 - 01/2017)
2. Miyairi, Shinichi: 4 articles (12/2019 - 01/2017)
3. Sano, Makoto: 3 articles (12/2019 - 01/2017)
4. Saito, Hiroaki: 3 articles (01/2018 - 01/2017)
5. Eisenbrand, G: 3 articles (06/2001 - 01/2001)
6. Meijer, L: 3 articles (06/2001 - 01/2001)
7. Choi, Yung Hyun: 2 articles (01/2021 - 09/2019)
8. Dilshara, Matharage Gayani: 2 articles (01/2021 - 09/2019)
9. Kim, Gi-Young: 2 articles (01/2021 - 09/2019)
10. Park, Cheol: 2 articles (01/2021 - 09/2019)

Related Diseases

1. Neoplasms (Cancer)
2. Insulin Resistance
3. Cognitive Dysfunction
4. Renal Cell Carcinoma (Grawitz Tumor)
5. Alzheimer Disease (Alzheimer's Disease)

Related Drugs and Biologics

1. indirubin
2. Cyclin-Dependent Kinases (cdk Proteins)
3. Therapeutic Uses
4. Amyloid beta-Peptides
5. Antineoplastic Agents (Antineoplastics)
6. Survivin
7. Proteasome Inhibitors
8. Presenilin-1
9. Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)
10. STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)

Related Therapies and Procedures

1. Intraventricular Infusions
2. Therapeutics
3. Chinese Traditional Medicine (Traditional Chinese Medicine)
4. Drug Therapy (Chemotherapy)